Introduction {#Sec1}
============

Over the past few years, clinical work and research on quality of life (QoL) has become increasingly important in improving both physical and mental health in children. In the field of attention deficit hyperactivity disorder (ADHD), several studies on QoL have been published and were included in a systematic review \[[@CR7]\]. This level of interest is not surprising due to the complexity of the relationships; QoL is not only influenced by the disorder itself, but also by many proximal (i.e. family, friendship) and distal (socioeconomic and cultural) factors. In addition to its core symptoms of attention deficit, hyperactivity and impulsivity, ADHD is associated with numerous developmental, cognitive, emotional, social and academic impairments \[[@CR12], [@CR17], [@CR25]\]. One possible reason for this might be that in ADHD, more than 80% of children and adults are likely to have at least one other psychiatric disorder and more than 50% are likely to have two \[[@CR10], [@CR23]\]. Thus, in ADHD, psychiatric comorbidity is the rule rather than the exception \[[@CR24]\]. These comorbidities, as well as the other proximal and distal factors, affect the QoL of both patients and their families \[[@CR7]\].

There is significant potential for overlap between the instruments designed to measure QoL and those used to measure psychopathology or functional impairment. Clear distinctions between symptoms (e.g. low mood or poor concentration) and their potential effects (i.e. functional impairment and/or reduced QoL), and also between functional impairment on the one hand and QoL on the other, are desirable \[[@CR7]\]. Otherwise, there is a clear risk that apparent QoL effects are so closely related to symptoms and functional impairment that their association with the disorder will become a tautology \[[@CR7]\]. In this context, it becomes evident that examining not only the relationship between QoL and categorical psychopathology (i.e. an ADHD diagnosis), but also the relationship with dimensional psychopathology (i.e. functional impairment and symptom scores), would result in improved understanding of the complex interplay of one or more disorders as well as of proximal and distal factors.

For an outcome as subjective as QoL, the influence of the rater's role should also be highlighted. A parent's rating of their child's QoL gives only one perspective of the overall impact of the illness on QoL. This may limit the validity of studies that do not ask children for their view on their own QoL. Such a difference is reflected, for example, by the only modest levels of agreement between the child's and other informants' ratings of QoL \[[@CR13], [@CR15]\], particularly with regard to non-observable aspects (such as emotional or social functioning). Parent ratings may, however, provide an important alternative perspective. Therefore, in studies on ADHD, measures of QoL as well as measures of psychopathology should include both a child- and a parent-rated version.

The aim of this analysis was to have a detailed look at the relationships between dimensional psychopathology and both parent- and child-rated QoL in ADHD. This analysis also evaluated the validity of the QoL concept, as described by Coghill et al. \[[@CR5]\]. By studying correlative considerations, the relationship between QoL and psychopathological problems may be better understood. The effects of medication on QoL in ADHD are reported in a companion paper \[[@CR8]\].

Methods {#Sec2}
=======

Study design {#Sec3}
------------

The open-label, prospective, multicentre, observational, post-marketing OBSEER (OBservation of Safety and Effectiveness of Equasym XL^®^ in Routine care) study was designed primarily to assess the effectiveness and safety of Equasym XL^®^[1](#Fn1){ref-type="fn"} (Shire Pharmaceuticals Ireland Limited, Ireland) in children and adolescents with ADHD and is described in full elsewhere \[[@CR8]\]. Here, pre-specified outcomes of QoL and the dimensional psychopathological profile (SDQ) are examined and related to each other cross-sectionally at the baseline visit in post hoc analyses.

Patients and treatment {#Sec4}
----------------------

Patients with ADHD (diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision \[DSM\]-IV-TR \[[@CR1]\] or the International Classification of Diseases \[ICD\]-10 criteria \[[@CR26]\]) aged 6--17 years and attending school were included if treatment with Equasym XL^®^ was planned by the treating physician. Patients either could have received prior medication or were medication naive. The study was conducted in accordance with local regulations and under the therapeutic responsibility of the attending physicians; ethics or institutional review board approval was not required for this study. Written informed consent was obtained from parents.

Assessments {#Sec5}
-----------

### QoL {#Sec6}

QoL was assessed using the Kinder Lebensqualitätsfragebogen (KINDL) questionnaire for the assessment of health-related QoL in childhood and adolescence \[[@CR18]\]. This is a validated tool comprising 24 items, with six subscores (*physical well*-*being*, *emotional well*-*being*, *self*-*esteem*, *family*, *friends* and *school*). Three versions were used according to age group: KID-KINDL was used for children aged 6--11 years; the self-reported KIDDO-KINDL for adolescents aged 12--17 years; and KINDL for parents of patients aged 6--17 years. Scores were transformed so that the range of possible values for the subscores and the total score was from 0 (most negative state) to 100 (most positive state).

### SDQ {#Sec7}

Parents were asked to complete a version of the Strengths and Difficulties Questionnaire (SDQ) that supplements the 25 core items on specific strengths and difficulties with an overall rating of whether their child has emotional or behavioural problems \[[@CR11], [@CR22]\]. Each of the 25 items is rated as being not true (0), somewhat true (1) or certainly true (2); each of the five subscales consists of five items, thus yielding scores between 0 and 10 for each subscale. Although the wording chosen for 10 of the 25 SDQ questions addresses positive behavioural attributes, five of these 10 item scores were inverted before being summed up. Thus, four of the SDQ subscales represent problem scores (*emotional symptoms, conduct problems, hyperactivity/inattention* and *peer problems*), which were added together to obtain a total difficulties score ranging from 0 to 40. The fifth subscale assesses the positive aspect of *prosocial behaviour*. Scores for each subscale were considered to be normal, borderline or abnormal. Total difficulties scores were considered to be normal (range 0--12), borderline (range 13--15) or abnormal (range 16--40).

Statistical analyses {#Sec8}
--------------------

The following outcomes were assessed: parent-rated dimensional psychopathological severity according to the SDQ and parent- and self-rated QoL at baseline.

Results presented are for the intent-to-treat population. Analysis of variance (ANOVA) modelling was performed to determine the effects of parent-rated SDQ subscale scores and total difficulties score on QoL. In subgroup analyses, patients were assigned to groups according to their diagnosis (ADHD only versus ADHD with conduct disorder) and treatment prior to starting Equasym XL^®^ (no treatment; or treatment with modified-release methylphenidate \[MPH\], immediate-release MPH \[MPH-IR\] administered once daily, MPH-IR administered several times per day or 'other', for which treatment was unspecified \[atomoxetine, amphetamine or insufficiently specified\]). Finally, correlation coefficients between the parent-reported SDQ subscales and total difficulties score and the parent- and self-rated QoL scales in the study (KINDL, KID-KINDL and KIDDO-KINDL) were calculated.

Scale means for parent ratings of both the SDQ and the KINDL scales were compared with those from the BELLA study, which assessed the prevalence of general and specific mental health problems in a representative sample of children and adolescents in Germany \[[@CR19], [@CR21]\].

Results {#Sec9}
=======

Study population {#Sec10}
----------------

In total, 852 patients were enrolled in the study. Thirty patients were excluded from the analysis due to invalid data; a further 101 patients were excluded because their SDQ data were missing or incomplete. Therefore, 721 patients were included in the analysis population. Baseline demographics are described elsewhere \[[@CR8]\].

Relationship between SDQ scores in the normal range and QoL {#Sec11}
-----------------------------------------------------------

Self-ratings of QoL from children aged 6--11 years showed that those with normal (range 0--5) scores on the *hyperactivity/inattention* subscale of the SDQ tended to achieve higher, albeit not significantly, scores on the KID-KINDL *friends* subscale than if they had borderline (6) or abnormal (range 7--10) SDQ scores (mean \[SD\] 68.4 \[19.8\] vs. 61.3 \[20.7\] and 65.5 \[22.7\]; *F* (2, 474) = 2.445; 0.05 \< *P* ≤ 0.1).

Children with normal (range 0--12) or borderline (range 13--15) SDQ total difficulties scores had higher scores, indicating better QoL, on the KINDL *friends* subscale than children with abnormal (range 16--40) SDQ scores (mean \[SD\] 63.2 \[19.4\] and 63.4 \[20.8\] vs. 58.7 \[21.2\]; *F* (2, 718) = 3.817; *P* ≤ 0.05). Compared with children with borderline or abnormal SDQ total difficulties scores, those with normal scores tended to rate themselves as more content on the KID-KINDL *school* subscale (mean \[SD\] 61.8 \[21.3\] vs. 53.6 \[23.0\] and 58.2 \[22.5\]; *F* (2, 474) = 2.589; 0.05 \< *P* ≤ 0.1).

Adolescents with normal SDQ total difficulties scores tended to show the highest QoL on the KIDDO-KINDL *family* subscale compared with those with borderline or abnormal scores (mean \[SD\] 73.5 \[20.9\] vs. 59.3 \[23.6\] and 66.6 \[22.9\]; *F* (2, 164) = 2.545; 0.05 \< *P* ≤ 0.1).

Correlation between severity of SDQ scores and QoL {#Sec12}
--------------------------------------------------

Correlation analyses showed that children with high SDQ total difficulties scores had significantly lower QoL on the parent-rated KINDL total score (*r* = −0.091; *P* ≤ 0.05) and on the subscales *emotional well*-*being* (*r* = −0.106; *P* ≤ 0.01) and *friends* (*r* = −0.131; *P* ≤ 0.01; Table [1](#Tab1){ref-type="table"}). There was also a similar trend for the subscale *self*-*esteem* (*r* = −0.063; 0.05 \< *P* ≤ 0.1).Table 1Correlation between the SDQ (parent ratings) and KINDL total scores and subscales (parent ratings) (*N* = 721)SDQKINDLTotal difficulties scoreSubscalesEmotional problemsConduct problemsHyperactivity/inattentionPeer problemsProsocial behaviourTotal score−*0.091*\*−*0.097*\*\*−0.055 ns−0.019 ns−*0.067*^T^0.017 nsSubscales Physical well-being−0.003 ns−0.038 ns0.005 ns0.031 ns0.00 ns−0.008 ns Emotional well-being−*0.106*\*\*−*0.096*\*−*0.069*^T^−0.032 ns−*0.084*\**0.063*^T^ Self-esteem−*0.063*^T^−0.057 ns−0.050 ns−0.003 ns−0.055 ns0.013 ns Family−0.032 ns−0.025 ns−0.055 ns0.009 ns−0.012 ns0.040 ns Friends−*0.131*\*\*−*0.118*\*\*−0.039 ns−0.053 ns−*0.134*\*\*0.003 ns School−0.043 ns−*0.073*^T^−0.024 ns−0.026 ns0.009 ns−0.038 nsItalics indicate significant or borderline significant results\* *P* ≤ 0.05; \*\* *P* ≤ 0.01; ^T^ 0.05 \< *P* ≤ 0.1; ns = not significant (two-tailed test, Spearman's rank correlation)

Children with high scores on the SDQ *emotional problems* subscale had significantly lower values on the parent-rated KINDL total score (*r* = --0.097; *P* ≤ 0.01) and on the subscales *emotional well*-*being* (*r* = −0.096; *P* ≤ 0.05) and *friends* (*r* = −0.118; *P* ≤ 0.01). A similar trend was found for the subscale *school* (*r* = −0.073; 0.05 \< *P* ≤ 0.1).

For the SDQ subscale *conduct problems,* children with higher scores tended to have lower QoL based on the parent-rated KINDL scale *emotional well*-*being* (*r* = −0.069; 0.05 \< *P* ≤ 0.1), although this was not significant.

There were no significant correlations between the SDQ subscale *hyperactivity/inattention* and any of the parent-rated KINDL subscales.

Children scoring high on the SDQ subscale *peer problems* had significantly lower QoL on the KINDL subscales *emotional well*-*being* (*r* = −0.084; *P* ≤ 0.05) and *friends* (*r* = −0.134; *P* ≤ 0.01). A similar trend was observed for the KINDL total score (*r* = −0.067; 0.05 \< *P* ≤ 0.1).

There were no significant correlations between psychopathology and QoL self-ratings from children aged 6--11 years (KID-KINDL; data not shown).

Adolescents who had high SDQ total difficulties scores had a significantly lower QoL on the KIDDO-KINDL subscales *self*-*esteem* (*r* = −0.170; *P* ≤ 0.05) and *friends* (*r* = −0.190; *P* ≤ 0.05), with a trend for lower QoL on the *family* subscale (*r* = −0.128; 0.05 \< *P* ≤ 0.1; Table [2](#Tab2){ref-type="table"}). Children with high scores on the SDQ subscale *emotional problems* tended to have lower scores on the KIDDO-KINDL subscales *self*-*esteem* (*r* = −0.143; 0.05 \< *P* ≤ 0.1) and *friends* (*r* = −0.137; 0.05 \< *P* ≤ 0.1).Table 2Correlation between the SDQ (parent ratings) and the KIDDO-KINDL total scores and subscales (patient ratings, age 12--17 years) (*N* = 167)SDQKIDDO-KINDLTotal difficulties scoreSubscalesEmotional problemsConduct problemsHyperactivity/inattentionPeer problemsProsocial behaviourTotal score−*0.159*\*−0.089 ns−0.042 ns−*0.174*\*−0.119 ns−0.025 nsSubscales Physical well-being−0.056 ns−0.091 ns0.014 ns−0.021 ns−0.047 ns−0.104 ns Emotional well-being−0.076 ns−0.030 ns0.004 ns−0.109 ns−0.069 ns−0.079 ns Self-esteem−*0.170*\*−*0.143*^T^−0.054 ns−0.098 ns−*0.153*\*−0.014 ns Family−*0.128*^T^−0.024 ns−0.120 ns−*0.155*\*−0.045 ns0.100 ns Friends−*0.190*\*−*0.137*^T^0.021 ns−*0.202*\*\*−0.143 ns−0.120 ns School−0.032 ns0.023 ns0.050 ns−*0.132*^T^−0.029 ns0.033 nsItalics indicate significant or borderline significant results\* *P* ≤ 0.05; \*\* *P* ≤ 0.01; ^T^ 0.05 \< *P* ≤ 0.1; ns = not significant (two-tailed test, Spearman's rank correlation)

Adolescents with high scores on the SDQ subscale *hyperactivity* showed a significantly lower QoL on the KIDDO-KINDL total score (*r* = −0.174; *P* ≤ 0.05), *family* (*r* = −0.155; *P* ≤ 0.05) and *friends* (*r* = −0.202; *P* ≤ 0.01; Table [2](#Tab2){ref-type="table"}). Furthermore, a similar trend was found for the KINDL subscale *school* (*r* = −0.132; 0.05 \< *P* ≤ 0.1)*.* Adolescents with high scores on the SDQ subscale *peer problems* tended to have a lower QoL on the KIDDO-KINDL subscale *self*-*esteem* (*r* = −0.153; *P* ≤ 0.05). There were no significant correlations between the SDQ subscales *conduct problems* or *prosocial behaviour* and any of the KIDDO-KINDL subscales.

Compared with the recent normative reference values for children and adolescents in Germany obtained in the epidemiological BELLA study \[[@CR19], [@CR21]\], children and adolescents with ADHD, as seen in the OBSEER study, were significantly more severely affected on every SDQ subscale and had a significantly lower QoL on every KINDL subscale (Table [3](#Tab3){ref-type="table"}).Table 3Comparison of scale means and effect sizes for parent-rated SDQ and KINDL scores at baseline in the OBSEER study with a reference population from the BELLA studyParent SDQ ratingsStudyCohen's d*t*-testBELLA \[[@CR21]\]; *n* = 2,406\
Mean (SD)OBSEER; *n* = 721\
Mean (SD)*t*SignificanceTotal difficulties7.8 (5.2)18.6 (4.3)−2.345.59\*\*\*Emotional symptoms1.8 (1.8)3.8 (2.5)−0.923.20\*\*\*Conduct problems1.9 (1.5)4.2 (1.7)−1.431.30\*\*\*Hyperactivity/inattention3.0 (2.2)6.9 (1.6)−2.023.41\*\*\*Peer problems1.4 (1.6)3.7 (1.4)−1.550.10\*\*\*Prosocial behaviour7.9 (1.7)6.7 (2.1)0.615.54\*\*\*Parent KINDL ratingsStudyCohen's *dt*-testBELLA \[[@CR19]\]; *n* = 2,863\
Mean (SD)OBSEER; *n* = 721\
Mean (SD)*t*SignificanceTotal score76.3 (10.1)62.9 (13.3)1.130.51\*\*\*Physical well-being76.5 (17.3)71.4 (18.3)0.36.52\*\*\*Emotional well-being80.8 (12.8)67.6 (17.6)0.922.51\*\*\*Self-esteem68.8 (14.2)55.1 (18.5)0.821.84\*\*\*Family77.7 (14.3)62.2 (19.4)0.924.95\*\*\*Friends78.0 (13.4)60.2 (20.9)1.024.31\*\*\*School76.0 (16.0)60.9 (18.7)0.920.10\*\*\*The Cohen's *d* effect size was calculated as small (0.20 ≥ *d* \< 0.50), medium (0.50 ≥ *d* \< 0.80) or large (0.80 ≥ *d*) \[[@CR6]\]*SD* standard deviation\*\*\* *P* ≤ 0.001

Comorbid conduct disorder and QoL {#Sec13}
---------------------------------

One-way ANOVA was used to test whether there were differences between scores on each scale associated with having an additional conduct disorder (Table [4](#Tab4){ref-type="table"}). Of note, SDQ scores, including those for the subscale *conduct problems*, did not differ between diagnostic groups. Similarly, there were no differences in QoL between children with or without additional conduct disorder from KINDL parent ratings.Table 4Diagnosis and QoL/behavioural problemsRating scale*N*DiagnosisANOVA*F* 90.0; *n* = 370*F* 90.1; *n* = 268*F*SignificanceMean (SD)Mean (SD)**QoL**Parent KINDL ratings Total score63863.1 (13.3)62.6 (13.4)0.269ns Physical well-being63872.1 (17.7)70.5 (19.2)1.157ns Emotional well-being63867.6 (17.9)67.2 (17.0)0.102ns Self-esteem63855.6 (18.4)54.8 (18.6)0.229ns Family63863.4 (18.7)60.8 (20.5)2.677ns Friends63859.5 (21.4)61.1 (20.6)0.915ns School68460.7 (18.8)61.0 (18.7)0.054nsPatient KID-KINDL ratings (age 6--11 years) Total score42966.6 (12.6)63.2 (15.0)6.246\* Physical well-being42972.2 (17.0)73.4 (17.9)0.754ns Emotional well-being42971.4 (16.5)70.6 (17.8)0.159ns Self-esteem42959.7 (19.2)54.2 (22.6)6.264\* Family42970.1 (18.6)63.5 (22.7)11.683\*\*\* Friends42966.6 (20.6)62.1 (23.7)4.230\* School42959.6 (21.8)55.7 (23.5)3.015^T^Patient KIDDO-KINDL ratings (age 12--17 years) Total score13769.7 (10.7)62.4 (14.1)11.715\*\*\* Physical well-being13776.3 (15.6)70.5 (16.3)5.011\* Emotional well-being13776.8 (15.5)69.3 (16.8)6.366\* Self-esteem13762.0 (17.9)55.9 (22.6)4.639\* Family13771.7 (20.2)58.8 (26.1)10.291\*\* Friends13772.5 (17.2)65.6 (22.4)4.660\* School13758.7 (16.9)54.2 (16.4)2.046ns**Behavioural problems**Parent SDQ ratings Total difficulties63818.3 (6.3)18.9 (6.3)0.857ns Emotional symptoms6383.8 (2.3)3.8 (2.6)0.365ns Conduct problems6384.0 (2.2)4.3 (2.3)1.044ns Hyperactivity/inattention6387.0 (2.2)7.0 (2.2)0.183ns Peer problems6383.6 (2.5)3.8 (2.4)1.163ns Prosocial behaviour6386.8 (2.0)6.6 (2.1)2.501ns*ANOVA* analysis of variance, *F90.0* disturbance of activity and attention, *F90.1* hyperkinetic conduct disorder, *QoL* quality of life, *SD* standard deviation\* *P* ≤ 0.05; \*\* *P* ≤ 0.01; \*\*\* *P* ≤ 0.001; ^T^ 0.05 \< *P* ≤ 0.1; ns = not significant

In contrast, self-ratings from children aged 6--11 years (KID-KINDL) showed that those with an additional conduct disorder had lower QoL than those without (Table [4](#Tab4){ref-type="table"}). This applied to the total score (*F* (1, 427) = 6.246; *P* ≤ 0.05) and the subscales *self*-*esteem* (*F* (1, 432) = 6.264; *P* ≤ 0.05), *family* (*F* (1, 430) = 11.683; *P* ≤ 0.001) and *friends* (*F* (1, 431) = 4.230; *P* ≤ 0.05). A similar trend was found for the subscale *school* (*F* (1, 430) = 3.015; 0.05 \< *P* ≤ 0.1), although this was not significant.

Adolescents aged 12--17 years (KIDDO-KINDL) showed a similar pattern to children for the QoL evaluation. The most impaired were the adolescents with an additional conduct disorder, with an effect on the total score (*F* (1, 135) = 11.715; *P* ≤ 0.001) and the scales *physical well*-*being* (*F* (1, 137) = 5.011; *P* ≤ 0.05), *emotional well*-*being* (*F* (1, 137) = 6.366; *P* ≤ 0.05), *self*-*esteem* (*F* (1, 137) = 4.639; *P* ≤ 0.05), *family* (*F* (1, 136) = 10.291; *P* ≤ 0.01) and *friends* (*F* (1, 137) = 4.660; *P* ≤ 0.05).

Medication subgroups and QoL {#Sec14}
----------------------------

When subgroups of patients were compared according to whether they had received prior medication or not, no statistically significant differences were found either for the KINDL or for the KID-KINDL (Table [5](#Tab5){ref-type="table"}). For the KIDDO-KINDL, adolescents receiving any prior medication scored significantly higher on the KIDDO-KINDL subscale *school* (*F* (1, 166) = 2.448; *P* ≤ 0.05) than those who had not received prior medication. A similar trend was found for the subscales *self*-*esteem* (*F* (1, 166) = 2.376; 0.05 \< *P* ≤ 0.1) and *family* (*F* (1, 166) = 1.997; 0.05 \< *P* ≤ 0.1). There were no significant differences in SDQ scores according to whether or not the patient had received prior medication.Table 5Medication subgroups and QoL/behavioural problemsRating scale*N*Prior treatmentANOVANone\
*n* = 187\
Mean (SD)MPH-IR once-daily\
*n* = 82\
Mean (SD)MPH-IR repeated\
*n* = 239\
Mean (SD)MPH-MR\
*n* = 179\
Mean (SD)Other/no specification\
*n* = 34\
Mean (SD)*F*Significance**QoL**Parent KINDL ratings Total score72163.4 (13.3)61.0 (12.9)62.8 (13.9)63.4 (12.5)63.3 (12.0)0.577ns Physical well-being72171.7 (18.5)70.1 (18.6)72.3 (18.3)70.4 (18.8)75.0 (13.9)0.723ns Emotional well-being72168.7 (15.9)65.0 (17.8)66.2 (18.9)69.7 (17.5)67.5 (15.2)1.584ns Self-esteem72154.9 (19.1)53.2 (20.7)55.6 (18.5)55.6 (16.8)54.4 (18.4)0.303ns Family72163.0 (19.0)58.8 (19.8)62.8 (20.1)62.4 (18.8)61.8 (19.7)0.784ns Friends72161.3 (21.3)59.8 (20.0)59.3 (20.8)61.4 (21.2)55.7 (20.8)0.770ns School72161.5 (19.5)58.9 (17.7)60.5 (19.4)61.0 (17.7)65.6 (17.2)0.852nsPatient KID-KINDL ratings (age 6--11 years) Total score47763.8 (13.3)65.8 (14.3)67.2 (14.1)65.4 (12.6)62.9 (16.1)1.349ns Physical well-being47774.4 (18.3)70.4 (15.3)71.9 (18.0)72.8 (16.9)74.0 (14.3)0.682ns Emotional well-being47770.3 (16.7)69.3 (17.3)73.2 (17.8)70.7 (16.5)69.1 (17.7)0.951ns Self-esteem47773.7 (21.4)61.5 (19.4)59.6 (21.5)56.6 (18.7)58.0 (23.3)2.171^T^ Family47766.0 (19.5)69.8 (20.8)70.1 (20.4)67.4 (20.1)59.0 (23.9)1.806ns Friends47764.4 (20.2)64.6 (21.6)67.0 (23.2)66.5 (20.6)60.8 (25.9)0.576ns School47753.9 (23.1)59.2 (23.4)61.3 (21.7)58.1 (20.2)56.6 (29.0)2.109^T^Patient KIDDO-KINDL ratings (age 12--17 years) Total score16763.3 (14.3)66.0 (10.3)69.0 (11.3)67.3 (14.0)66.2 (7.9)1.250ns Physical well-being16771.7 (18.1)76.2 (17.1)75.1 (18.0)73.0 (14.4)73.3 (17.5)0.340ns Emotional well-being16775.6 (18.1)68.8 (11.4)73.9 (15.4)73.8 (17.5)71.6 (10.2)0.571ns Self-esteem16751.7 (20.5)60.6 (15.4)61.5 (16.3)62.6 (19.4)61.9 (21.0)2.376^T^ Family16761.6 (27.3)63.5 (18.7)72.9 (21.9)68.1 (21.5)58.5 (13.2)1.997^T^ Friends16769.1 (20.7)66.5 (15.6)70.7 (18.5)68.8 (20.8)70.5 (16.3)0.165ns School16750.1 (17.7)60.2 (15.3)59.7 (16.6)57.6 (17.5)61.4 (14.2)2.448\***Behavioural problems**Parent SDQ ratings Total difficulties72119.0 (6.5)17.4 (5.4)18.6 (6.7)18.7 (6.0)18.2 (5.6)0.993ns Emotional symptoms7213.9 (2.4)3.6 (2.4)3.9 (2.6)3.7 (2.4)3.5 (2.6)0.498ns Conduct problems7214.4 (2.4)3.7 (2.2)4.1 (2.4)4.2 (2.1)4.4 (1.8)1.494ns Hyperactivity/inattention7217.0 (2.2)6.8 (1.9)6.7 (2.1)7.3 (2.3)6.9 (2.4)1.778ns Peer problems7213.8 (2.5)3.3 (2.2)3.9 (2.6)3.5 (2.3)3.4 (2.4)1.270ns Prosocial behaviour7216.6 (2.0)6.6 (2.0)6.6 (2.1)6.8 (2.1)7.1 (1.9)0.777ns*ANOVA* analysis of variance, *IR* immediate release, *MPH* methylphenidate, *MR* modified release, *QoL* quality of life, *SD* standard deviation\* *P* ≤ 0.05; ^T^ 0.05 \< *P* ≤ 0.1; ns = not significant

Discussion {#Sec15}
==========

ADHD is associated with a variety of behavioural problems; therefore, knowledge of the complete psychopathological profile is important for treatment decisions and follow-up. Danckaerts et al. \[[@CR7]\] showed that a robust negative effect on QoL was reported by the parents of children with ADHD across a broad range of psychopathology symptoms. Additional comorbid disorders, such as oppositional defiant disorder \[[@CR16]\], and increased symptom levels also seem to predict reduced QoL \[[@CR14]\]. For this reason, it is useful to know what influence psychopathological profile has on QoL. We investigated the relationship between these two parameters in this analysis of the observational OBSEER trial. An advantage of this study is that self-assessment of children was included and thus findings are not limited to just the views of parents or caregivers, unlike the majority of QoL studies \[[@CR7]\].

Our results show that classifying scores on the SDQ subscale *hyperactivity/inattention* and the SDQ total problem score as normal, borderline or abnormal did not sufficiently differentiate between children's QoL as rated by their parents. This may be due to the fact that, in this fairly homogeneous clinical sample, most children with ADHD had low QoL. Indeed, this was reflected in both parent and self-ratings. Thus, it is probable that an apparent 'bottom effect' did not allow QoL to be adequately differentiated using severity-categorized SDQ values in this sample.

Although ADHD symptom severity appeared to have little influence on QoL, having a comorbid conduct disorder had a substantial impact. However, this was evident only on self-ratings; ratings from parents did not differ between QoL of children with ADHD only and those with ADHD plus a conduct disorder. The findings indicate that adolescents, in particular, experience a significant decrease in QoL if they have a comorbid conduct disorder. Therapists should consider this aspect when planning multimodal treatment and adjust the sequence of interventions according to the subjective view of impairment given by the patient.

Parent and child ratings did not identify any significant differences in QoL due to prior medication. However, adolescents not taking medication at baseline had significantly lower QoL on the KIDDO-KINDL subscale *school* compared with adolescents taking any MPH medication. A similar trend was found for the subscales *self*-*esteem* and *family*, but the majority of scales showed no differences. Hence, the positive effect of medication on QoL seen in some previous trials \[[@CR4], [@CR9]\] was observed only as an overall trend in this study.

Scores for the SDQ subscales and total difficulties had varying associations with the QoL assessment scales used in the OBSEER study. For parental ratings, the highest correlation (negative) was seen between the SDQ subscale *peer problems* and the KINDL subscale *friends*. Thus, children with lower QoL according to the subscale *friends* had significantly more problems with their peers. It is likely that these scales measure similar, but opposing, aspects of behaviour. Furthermore, it was found that a high psychopathological value on the SDQ subscales *peer problems*, *emotional problems* and *total problems* is accompanied by lower QoL on the KINDL subscales *emotional well*-*being*, *friends* and total score. However, these significant relationships are based on low correlation coefficients and thus need to be interpreted with caution. In addition, adolescents with high scores on the SDQ scale *hyperactivity* had a significantly lower QoL (KIDDO-KINDL). This association was most notable for the total score and the subscales *family* and *friends*.

The results of this study are consistent with the results of another observational trial, the ADORE study \[[@CR2]\], which recruited a comparable sample (with regard to sample size and demographic characteristics) of children with ADHD across Europe. In that study, baseline SDQ values were similar to those in the current study, and the QoL of children with ADHD in the ADORE study was markedly lower at baseline \[[@CR20]\] than the norms for children in the community \[[@CR3]\].

However, according to SDQ scales, a relatively high proportion of children and adolescents in the OBSEER study were classified as having impaired psychopathology. A total of 67.1% of children were classified as 'abnormal' on the SDQ total score and 57.1% on the SDQ subscale *hyperactivity/inattention,* compared with 6--9% of children in the normative BELLA study \[[@CR21]\].

A limitation of our analysis is that the clinical diagnoses were not based on structured interviews, which may limit the reliability of the findings. Furthermore, for the ANOVA, the multiple testing of correlations was not adjusted and therefore should be regarded as exploratory. Finally, the prior medication status of patients was not identified at randomization, which makes it difficult to interpret the presence or absence of meaningful differences.

In addition to providing further evidence that QoL is low in children with ADHD, our results show that different psychopathological problems influence QoL in different ways. According to child and adolescent self-ratings, having a comorbid conduct disorder was associated with significantly lower QoL. Based on our results, it is recommended that when assessing QoL, children's ratings should be used in conjunction with parental ratings for a complete picture.
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